Treatment of Fabry disease in ERT naive patients and ERT experienced patients

摘要

A dosing regimen for the treatment of a patient's Fabry disease is provided. Certain methods relate to the treatment of ERT experienced Fabry patients or ERT naive (untreated) Fabry patients. Certain methods include administering to a patient about 123 mg of free base equivalent of migrastat to improve left ventricular weight and / or to improve podocyte globotriosylceramide. [Selection] Figure 3